Tandem high-dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin therapy given between first and second HDT allows second peripheral blood stem cell transplantation without red blood cell transfusionBARON, Frédéric; FRERE, Pascale; FILLET, Georges et al.British journal of haematology. 2003, Vol 123, Num 1, pp 103-105, issn 0007-1048, 3 p.Article

Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftmentBARON, Frédéric; FRERE, Pascale; FILLET, Georges et al.Clinical cancer research. 2003, Vol 9, Num 15, pp 5566-5572, issn 1078-0432, 7 p.Article

Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571BARON, Frédéric; FRERE, Pascale; FILLET, Georges et al.Haematologica (Roma). 2001, Vol 86, Num 9, pp 993-994, issn 0390-6078Article

Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma: final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia GroupLABAR, Boris; SUCIU, Stefan; SINNIGE, Harm et al.Haematologica (Roma). 2010, Vol 95, Num 9, pp 1489-1495, issn 0390-6078, 7 p.Article

Efficacy of recombinant human erythropoietin therapy started one month after autologous peripheral blood stem cell transplantationVANSTRAELEN, Gaëtan; BARON, Frédéric; FRERE, Pascale et al.Haematologica (Roma). 2005, Vol 90, Num 9, pp 1269-1270, issn 0390-6078, 2 p.Article

Immunothérapie du cancer par minigreffe de cellules souches hématopoïétiques = Nonmyeloablative stem cell transplantation as cancer immunotherapyBEGUIN, Yves; WILLEMS, Evelyne; VANSTRAELEN, Gaétan et al.Revue médicale suisse. 2005, Vol 1, Num 30, pp 1973-1977, issn 1660-9379, 5 p.Article

Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients ≤ 50 years old in first complete remission : results of the EORTC ALL-3 trialLABAR, Boris; SUCIU, Stefan; JAKSIC, Branimir et al.Haematologica (Roma). 2004, Vol 89, Num 7, pp 809-817, issn 0390-6078, 9 p.Article

Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemiaPIRON, Maude; LOO, Martine; GOTHOT, André et al.Blood. 2001, Vol 97, Num 2, pp 442-448, issn 0006-4971Article

High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 TrialWILLEMZE, Roelof; SUCIU, Stefan; FABBIANO, Francesco et al.Journal of clinical oncology. 2014, Vol 32, Num 3, pp 219-228, issn 0732-183X, 10 p.Article

Whole-body positron emission tomography using ¹⁸F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's diseaseJERUSALEM, Guy; BEGUIN, Yves; FASSOTIE, Marie-France et al.Haematologica (Roma). 2001, Vol 86, Num 3, pp 266-273, issn 0390-6078Article

CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients : A study by the groupe d'etude des lymphomes de l'adulteBONNET, Christophe; FILLET, Georges; TILLY, Hervé et al.Journal of clinical oncology. 2007, Vol 25, Num 7, pp 787-792, issn 0732-183X, 6 p.Article

Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphomaGISSELBRECHT, Christian; LEPAGE, Eric; HERMINE, Olivier et al.Journal of clinical oncology. 2002, Vol 20, Num 10, pp 2472-2479, issn 0732-183XArticle

Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantationBARON, Frédéric; GOTHOT, André; SALMON, Jean-Paul et al.British journal of haematology. 2000, Vol 111, Num 3, pp 745-753, issn 0007-1048Article

CHIC cells: a novel ALK+ cell line derived from a relapsed anaplastic large cell lymphomaTHIELEN, Caroline; BISIG, Bettina; GOFFLOT, Stéphanie et al.British journal of haematology. 2011, Vol 152, Num 3, pp 356-360, issn 0007-1048, 5 p.Article

Phase III randomized study comparing 5 or 10 μg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignanciesANDRE, Marc; BAUDOUX, Etienne; VERMEULEN, Philippe et al.Transfusion (Philadelphia, PA). 2003, Vol 43, Num 1, pp 50-57, issn 0041-1132, 8 p.Article

Pre-emptive immunotherapy with CD8-depleted donor lymphocytes after CD34-selected allogeneic peripheral blood stem cell transplantationBARON, Frédéric; SIQUET, Jean; SCHAAF-LAFONTAINE, Nicole et al.Haematologica (Roma). 2002, Vol 87, Num 1, pp 78-88, issn 0390-6078Article

Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphomaTILLY, Hervé; LEPAGE, Eric; GISSELBRECHT, Christian et al.Blood. 2003, Vol 102, Num 13, pp 4284-4289, issn 0006-4971, 6 p.Article

T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantationBARON, Frédéric; SCHAAF-LAFONTAINE, Nicole; HUMBLET-BARON, Stéphanie et al.Transplantation. 2003, Vol 76, Num 12, pp 1705-1713, issn 0041-1337, 9 p.Article

Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantationSAUTOIS, Brieuc; BAUDOUX, Etienne; SALMON, Jean-Paul et al.Haematologica (Roma). 2001, Vol 86, Num 11, pp 1209-1218, issn 0390-6078Article